ALGERT GLOBAL LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$35
-57.8%
14,808
+12.8%
0.00%
-80.0%
Q4 2022$83
-99.9%
13,1250.0%0.01%
-44.4%
Q3 2022$142,000
-68.6%
13,125
-66.9%
0.01%
-73.5%
Q2 2022$452,000
-64.7%
39,642
-71.8%
0.03%
-59.5%
Q1 2022$1,282,000
+440.9%
140,712
+1424.5%
0.08%
+162.5%
Q3 2021$237,0009,2300.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders